This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Report of a Case

MAJOR LESLIE NICHOLAS

Arch Derm Syphilol. 1946;54(1):57-59.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE BEST treatment of erysipeloid is debatable. Klauder¹ stated "that it is difficult to evaluate different methods of treatment, since in many cases erysipeloid apparently runs a self-limited course and splinting the hand may be the only required treatment." In an experimental study, Klauder and Rule² reported a survival of 12.5 per cent of mice treated with a sulfonamide compound after inoculation with Erysipelothrix rhusiopathiae; this is surely a limited therapeutic effect of sulfanilamide, sulfapyridine, sulfathiazole and sulfadiazine. They also reported that sulfonamide compounds were ineffective in the treatment of patients with erysipeloid.

The opposite view has been expressed by other authors. Schoch and Shelmire³ and Eckstein⁴ reported success with sulfanilamide; Kulchar and Rosenberg⁵ cured erysipeloid with sulfathiazole. In the septicemic form with endocarditis, neither sulfanilamide⁶ nor sulfathiazole⁷ proved to be effective therapeutic agents.

The use of anti-erysipelothrix-rhusiopathiae serum was recommended . . . [Full Text PDF of this Article]

Author Affiliations
MEDICAL CORPS, ARMY OF THE UNITED STATES

Footnotes
Instructor in Dermatology and Syphilology, Graduate School of Medicine, University of Pennsylvania, on leave of absence.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?